ALDH inhibition has a synthetically lethal effect in AML cells when combined with glutathione peroxidase-4 inhibition [74], and it can overcome both bortezomib and cytarabine resistance in Down syndrome-associated AML [75]. This evidence concerns the gene GPX4 and acute myeloid leukemia.